May 28, 2020 Report Open Access

James Watson on the behalf of 146 signatories

JSON-LD (schema.org) Export

{
  "inLanguage": {
    "alternateName": "eng", 
    "@type": "Language", 
    "name": "English"
  }, 
  "description": "<p>Open letter to MR Mehra, SS Desai, F Ruschitzka, and AN Patel, authors of</p>\n\n<p><strong>&ldquo;Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis&rdquo;. Lancet. 2020 May 22:S0140-6736(20)31180-6. doi: 10.1016/S0140-6736(20)31180-6. PMID: 32450107</strong></p>\n\n<p>and to Richard Horton (editor of The Lancet).</p>", 
  "license": "https://creativecommons.org/licenses/by/4.0/legalcode", 
  "creator": [
    {
      "affiliation": "Mahidol Oxford Tropical Medicine Research Unit", 
      "@type": "Person", 
      "name": "James Watson on the behalf of 146 signatories"
    }
  ], 
  "headline": "An open letter to Mehra et al and The Lancet", 
  "image": "https://zenodo.org/static/img/logos/zenodo-gradient-round.svg", 
  "datePublished": "2020-05-28", 
  "url": "https://zenodo.org/record/3864691", 
  "version": "2", 
  "keywords": [
    "Hydroxychloroquine", 
    "The Lancet", 
    "Open Science"
  ], 
  "@context": "https://schema.org/", 
  "identifier": "https://doi.org/10.5281/zenodo.3864691", 
  "@id": "https://doi.org/10.5281/zenodo.3864691", 
  "@type": "ScholarlyArticle", 
  "name": "An open letter to Mehra et al and The Lancet"
}